989 Results
December Issues of APA Journals Feature Research on the Amygdala, PTSD, and Discrimination
The latest issues of two American Psychiatric Association journals, The American Journal of Psychiatry, and Psychiatric Services, are now available online.
Clinical Practice with Clozapine Post-REMS Elimination: How does that impact my patients?
Join us on Mar. 7 at noon to to discuss the elimination of REMS and how we can continue to make clozapine accessible.
Personal Perspectives on Early Psychosis, Part 2
This episode is the second of a two-part discussion about early psychosis led by Dr. Ken Duckworth.
Member Obituaries
American Psychiatric Association honors the lives and legacies of its member psychiatrists and their contributions to mental health and psychiatry. APA hosts member obituaries, submitted by contributors.
PsychNews Special Report: Clozapine Revisited—Updates to the Gold Standard
In this episode of PsychNews Special Report, we explore the evolving landscape of clozapine therapy, reaffirming its role as the gold standard for treatment-resistant schizophrenia and examining its unique benefits in reducing suicidality.
Mental Health Pathfinders: The High Stakes of Gambling: Addiction, Apps, and Mental Health with Dr. James Sherer
Dr. James Sherer joins us to break down the sharp rise in gambling addiction fueled by online platforms and sports betting.
How to Help When Dementia Leads to Agitation
Dementia is a rapidly growing public health problem affecting around 50 million people around the world, according to a recent World Health Organization (WHO) report. It is a major cause of disability and dependency among adults, often causing significant caregiving and financial stress on families. People with dementia may develop agitation or psychosis which can be very challenging for caregivers. Agitation is a state of excessive physical movement or aggression associated with emotional dist
New Study Looks at What it Means to Recover from Mental Illness
A new study examining recovery after first-episode psychosis found that based on a standard definition of recovery, 32% of people are in clinical recovery, including 50% of those with bipolar disorder and 23% of those with schizophrenia spectrum disorders (Asbo et al., 2022). The study authors also found that, “as most of our participants were in psychotic symptom remission, psychosis appears well managed for most.”
The Opioid Crisis: Impact, Challenges, and Paths to Recovery
Opioids are a class of drugs that include prescription painkillers like oxycodone and hydrocodone, illegal drugs like heroin, and synthetic opioids such as fentanyl. These substances bind to opioid receptors in the brain, producing pain relief and euphoria. Prolonged use can lead to tolerance, dependence, and addiction, characteristic of opioid use disorder (OUD). Fentanyl, due to its potency, has played a particularly lethal role in the opioid crisis.
New Research Identifies Critical Gaps in Mental Health Care for Adults with Schizophrenia Spectrum Disorders
New research finds that adults with schizophrenia spectrum disorders have high rates of comorbid mental and substance use disorders and significant social and economic disadvantages, and only 26% received minimally adequate treatment. Meeting the needs of people with schizophrenia spectrum disorders will require innovative interventions and implementation to improve access to and use of evidence-based approaches, the authors argue. The research was published today in Psychiatric Services in Adva
Two in Five Americans Say Their Mood Worsens in Winter; 29% Say “Falling Back” Hurts Their Mental Health
As the nation “falls back” to standard time, Americans are twice as likely to say their mood declines in the winter (41%) as they are to say it improves (22%). But, as also found in the latest Healthy Minds Monthly Poll from the American Psychiatric Association (APA), when spring comes around, 61% report feeling better.
New Titles Available from APA Publishing Include Guidance on Treating Addiction to Tobacco, Learning and Applying the DSM-5-TR®
American Psychiatric Association (APA) Publishing recently released books on a wide range of topics, from psychodermatology to transcranial magnetic stimulation and studying the DSM-5-TR®. The new titles are primarily intended for use by psychiatrists, psychiatric residents and medical students, social workers, and other behavioral health and mental health professionals.